LATEST NEWS IN PROSTATE CANCER
Provenge in 2012
Doctors finally seem to be comfortable with starting Provenge, a recently FDA approved immune therapy for prostate cancer. Dendreon, the manufacturer of Provenge, just reported a sharp uptick in their quarterly financials, indicating that the use of Provenge is increasing as doctors increase the amount of the drug they order.